記住我
Zhou M, Wang H, Zeng X, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2019; 394(10204): 1145–1158. DOI: https://doi.org/10.1016/S0140-6736(19)30427-1
Kassebaum NJ, Barber RM, Bhutta ZA, et al. Global, regional, and national levels of maternal mortality, 1990–2015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016; 388(10053): 1775–1812. DOI: https://doi.org/10.1016/S0140-6736(16)31470-2
Members ATF, Rydén L, Grant PJ, et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The task force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). European Heart Journal. 2013; 34(39): 3035–3087. DOI: https://doi.org/10.1093/eurheartj/eht108
Read SH, Fischbacher CM, Colhoun HM, et al. Trends in incidence and case fatality of acute myocardial infarction, angina and coronary revascularisation in people with and without type 2 diabetes in Scotland between 2006 and 2015. Diabetologia. 2019; 62(3): 418–425. DOI: https://doi.org/10.1007/s00125-018-4796-7
Zhou B, Lu Y, Hajifathalian K, et al. Worldwide trends in diabetes since 1980: A pooled analysis of 751 population-based studies with 4·4 million participants. Lancet. 2016; 387(10027): 1513–1530. DOI: https://doi.org/10.1016/S0140-6736(16)00618-8
Branch CMAD. Guidelines for the prevention and treatment of type 2 diabetes in China (2017 edition). Chinese Journal of Practical Internal Medicine. 2017; 38(4): 34–86.
McGuire H, Longson D, Adler A, Farmer A, Lewin I. Management of type 2 diabetes in adults: summary of updated NICE guidance. BMJ. 2016; 353: i1575. DOI: https://doi.org/10.1136/bmj.i1575
Kengne AP, Patel A, Marre M, et al. Contemporary model for cardiovascular risk prediction in people with type 2 diabetes. European Journal of Cardiovascular Prevention and Rehabilitation. 2011; 18(3): 393–398. DOI: https://doi.org/10.1177/1741826710394270
Mukamal K, Kizer J, Djoussé L, et al. Prediction and classification of cardiovascular disease risk in older adults with diabetes. Diabetologia. 2013; 56(2): 275–283. DOI: https://doi.org/10.1007/s00125-012-2772-1
Elley CR, Robinson E, Kenealy T, Bramley D, Drury PL. Derivation and validation of a new cardiovascular risk score for people with type 2 diabetes: The new zealand diabetes cohort study. Diabetes Care. 2010; 33(6): 1347–1352. DOI: https://doi.org/10.2337/dc09-1444
Davis W, Knuiman M, Davis T. An Australian cardiovascular risk equation for type 2 diabetes: The Fremantle Diabetes Study. Internal Medicine Journal. 2010; 40(4): 286–292. DOI: https://doi.org/10.1111/j.1445-5994.2009.01958.x
Zethelius B, Eliasson B, Eeg-Olofsson K, Svensson A-M, Gudbjörnsdottir S, Cederholm J. A new model for 5-year risk of cardiovascular disease in type 2 diabetes, from the Swedish National Diabetes Register (NDR). Diabetes Research and Clinical Practice. 2011; 93(2): 276–284. DOI: https://doi.org/10.1016/j.diabres.2011.05.037
Basu S, Sussman JB, Berkowitz SA, et al. Validation of risk equations for complications of type 2 diabetes (RECODe) using individual participant data from diverse longitudinal cohorts in the US. 2018; 41(3): 586–595. DOI: https://doi.org/10.2337/dc17-2002
Peters SA, Huxley RR, Woodward M. Diabetes as risk factor for incident coronary heart disease in women compared with men: A systematic review and meta-analysis of 64 cohorts including 858,507 individuals and 28,203 coronary events. In Springer; 2014. DOI: https://doi.org/10.1007/s00125-014-3260-6
Shah AD, Langenberg C, Rapsomaniki E, et al. Type 2 diabetes and incidence of cardiovascular diseases: A cohort study in 1.9 million people. 2015; 3(2): 105–113. DOI: https://doi.org/10.1016/S2213-8587(14)70219-0
Van der Leeuw J, Van Dieren S, Beulens J, et al. The validation of cardiovascular risk scores for patients with type 2 diabetes mellitus. 2015; 101(3): 222–229. DOI: https://doi.org/10.1136/heartjnl-2014-306068
Yu D, Shang J, Cai Y, et al. Derivation and external validation of a risk prediction algorithm to estimate future risk of cardiovascular death among patients with type 2 diabetes and incident diabetic nephropathy: Prospective cohort study. BMJ Open Diabetes Research and Care. 2019; 7(1). DOI: https://doi.org/10.1136/bmjdrc-2019-000735
Quan J, Pang D, Li TK, et al. Risk prediction scores for mortality, cerebrovascular, and heart disease among Chinese people with type 2 diabetes. 2019; 104(12): 5823–5830. DOI: https://doi.org/10.1210/jc.2019-00731
Zhang X, Miao SM, Dai ZLJCDM. Research and application of conversion from clinical data to OMOP common data model. China Digital Medicine. 2018; 13(10): 69–72.
Read SH, van Diepen M, Colhoun HM, et al. Performance of cardiovascular disease risk scores in people diagnosed with type 2 diabetes: External validation using data from the national Scottish diabetes register. Diabetes Care. 2018; 41(9): 2010–2018. DOI: https://doi.org/10.2337/dc18-0578
Zhang X, Wang L, Miao S, et al. Analysis of treatment pathways for three chronic diseases using OMOP CDM. Journal of Medical Systems. 2018; 42(12): 260. DOI: https://doi.org/10.1007/s10916-018-1076-5
Marshall A, Altman DG, Holder RL. Combining estimates of interest in prognostic modelling. 2009.
Leening MJ, Steyerberg EW, Van Calster B, DAgostino RB, Sr, Pencina M. Net reclassification improvement and integrated discrimination improvement require calibrated models: Relevance from a marker and model perspective. Statistics in Medicine. 2014; 33(19): 3415–3418. DOI: https://doi.org/10.1002/sim.6133
Hippisley-Cox J, Coupland C, Vinogradova Y, et al. Predicting cardiovascular risk in England and Wales: Prospective derivation and validation of QRISK2. 2008; 336(7659): 1475–1482. DOI: https://doi.org/10.1136/bmj.39609.449676.25
Stevens RJ, Poppe KK. Validation of clinical prediction models: What does the “calibration slope” really measure? Journal of Clinical Epidemiology. 2020; 118: 93–99. DOI: https://doi.org/10.1016/j.jclinepi.2019.09.016
Wan EYF, Fong DYT, Fung CSC, Lam CLKJJoD, Complications I. Incidence and predictors for cardiovascular disease in Chinese patients with type 2 diabetes mellitus—a population-based retrospective cohort study. 2016; 30(3): 444–450. DOI: https://doi.org/10.1016/j.jdiacomp.2015.12.010
Zhao W, Katzmarzyk PT, Horswell R, Wang Y, Johnson J, Hu G. Sex differences in the risk of stroke and HbA1c among diabetic patients. Diabetologia. 2014; 57(5): 918–926. DOI: https://doi.org/10.1007/s00125-014-3190-3
Currie CJ, Peters JR, Tynan A, et al. Survival as a function of HbA1c in people with type 2 diabetes: A retrospective cohort study. 2010; 375(9713): 481–489. DOI: https://doi.org/10.1016/S0140-6736(09)61969-3
Kontopantelis E, Springate DA, Reeves D, et al. Glucose, blood pressure and cholesterol levels and their relationships to clinical outcomes in type 2 diabetes: A retrospective cohort study. 2015; 58(3): 505–518. DOI: https://doi.org/10.1007/s00125-014-3473-8
Wan EYF, Fong DYT, Fung CSC, et al. Development of a cardiovascular diseases risk prediction model and tools for Chinese patients with type 2 diabetes mellitus: A population-based retrospective cohort study. Diabetes, Obesity and Metabolism. 2018; 20(2): 309–318. DOI: https://doi.org/10.1111/dom.13066
Yang X, Li J, Hu D, Chen J, et al. Predicting the 10-year risks of atherosclerotic cardiovascular disease in Chinese population. Circulation. 2016; 134(19): 1430–1440. DOI: https://doi.org/10.1161/CIRCULATIONAHA.116.022367
Chia YC, Gray SYW, Ching SM, Lim HM, Chinna K. Validation of the Framingham general cardiovascular risk score in a multiethnic Asian population: A retrospective cohort study. 2015; 5(5): e007324. DOI: https://doi.org/10.1136/bmjopen-2014-007324
Sun C, Xu F, Liu X, et al. Comparison of validation and application on various cardiovascular disease mortality risk prediction models in Chinese rural population. Scientific Reports. 2017; 7(1): 43227. DOI: https://doi.org/10.1038/srep43227
Asia Pacific Cohort Studies C, Barzi F, Patel A, et al. Cardiovascular risk prediction tools for populations in Asia. Journal of Epidemiol Community Health. 2007; 61(2): 115–121. DOI: https://doi.org/10.1136/jech.2005.044842
留言 (0)